Amgen (AMGN) EVP James Bradner granted RSUs, options; 407 shares withheld for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amgen Inc. executive James E. Bradner reported routine equity compensation activity. On May 5, 2026, he acquired 3,337 Restricted Stock Units (RSUs) at $0.00 per share, which vest in four equal annual installments of 25% each starting on May 5, 2027. These shares include 1,332 Dividend Equivalents (DEs) that will be paid in common stock following the same vesting schedule. He was also granted 21,773 non-qualified stock options with a $329.59 exercise price, vesting 25% annually from May 5, 2027 and expiring on May 5, 2036. On May 6, 2026, 407 shares of common stock were disposed of at $329.59 per share to cover tax obligations, a non-market tax-withholding disposition. After these transactions, Bradner directly holds 30,462 shares of Amgen common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Bradner James E.
Role
EVP, Research and Development
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 407 | $329.59 | $134K |
| Grant/Award | Nqso (Right to Buy) | 21,773 | $329.59 | $7.18M |
| Grant/Award | Common Stock | 3,337 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 30,462 shares (Direct, null);
Nqso (Right to Buy) — 21,773 shares (Direct, null)
Footnotes (1)
- The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 1,332 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Key Figures
RSU grant: 3,337 RSUs
Dividend Equivalents: 1,332 DEs
Stock options granted: 21,773 options
+3 more
6 metrics
RSU grant
3,337 RSUs
Granted May 5, 2026; vest 25% annually starting May 5, 2027
Dividend Equivalents
1,332 DEs
Credited to unvested RSUs; paid in shares on RSU vesting schedule
Stock options granted
21,773 options
Non-qualified options at $329.59 exercise price; expire May 5, 2036
Option exercise price
$329.59/share
Exercise price for 21,773 non-qualified stock options granted May 5, 2026
Tax-withheld shares
407 shares
Shares disposed at $329.59 on May 6, 2026 to cover tax liability
Post-transaction holdings
30,462 shares
Direct Amgen common stock holdings after reported transactions
Key Terms
Restricted Stock Units (RSUs), Dividend Equivalents (DEs), non-qualified stock options, Equity Incentive Plan, +1 more
5 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 1,332 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan"
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
tax-withholding disposition financial
"transaction_action: tax-withholding disposition, transaction_code_description: Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
